[The 'Colon cancer laparoscopic or open resection' (COLOR) trial].
The value of laparoscopic surgery for colorectal malignancy as compared with open surgery will be determined in the COLOR-trial. The disease-free survival time is the primary end point. Twenty-one hospitals in the Netherlands and Scandinavia will participate in the trial. In the COLOR trial 1500 patients with colon carcinoma will be randomised for either a laparoscopic or open colon resection.